Cryoport (CYRX) executive compensation, 2026 proxy

Jerrell W. Shelton, President and Chief Executive Officer, was paid $2.4M in 2025, up 27% from $1.9M the year before. The CEO-to-median-employee pay ratio was 37:1, on median employee pay of $64,653.

Filed
April 22, 2026
Annual meeting
June 5, 2026
Pay year
2025
Named executives
4
CEO total pay
$2.4M+27% vs prior year
CEO to median employee
37:1median $64,653
CEO pay in equity
21%$499,169 in awards
Prior say-on-pay support
95%of votes cast
CEO Target Bonus %
100%Percentage of annual base salary
2025 Revenue
$176.2M12% year-over-year growth
Commercial CGT Growth
29%Increase year-over-year
Say-on-Pay Support
95%Previous advisory vote

How Shelton was paid

$2.4M in total for 2025, as reported in the Summary Compensation Table. Equity awards are valued at grant, not at what they turned out to be worth.

Salary41%Stock awards8%Option awards13%Non-equity incentive38%

Named executive officers

ExecutiveTotal
Jerrell W. SheltonPresident and Chief Executive Officer$2,375,524
Robert S. StefanovichSenior Vice President and Chief Financial Officer$1,119,615
Mark W. Sawicki, Ph.D.Chief Scientific Officer$986,061
Edward ZecchiniSenior Vice President and Chief Digital and Technology Officer$1,088,029

What changed and why

  • $176.2MTotal revenue for 2025 increased 12.4% year-over-year to $176.2 million.
  • $2.4MCEO total compensation increased to $2,375,524 in 2025 from $1,874,870 in 2024.
  • $33.4MCommercial cell and gene therapy revenue grew 28.6% to a record $33.4 million.
  • 95%Stockholders approved the previous say-on-pay proposal with approximately 95% support.
  • Frederic W. Cook & Co., Inc. served as the independent compensation consultant.

About this page

Figures are automated and can be wrong; check the filing for the exact numbers. Totals follow SEC rules, which value stock and option awards at grant. Read the DEF 14A proxy statement for footnotes and the compensation committee's full reasoning.